Non-mitogenic acidic fibroblast growth factor reduces intestinal dysfunction induced by ischemia and reperfusion injury in rats

Journal of Gastroenterology and Hepatology (Australia)

Volumn 22, Issue 3, 2007, Pages 363-370

  Li, Hai Hong ^a,b   Fu, Xiao Bing ^a   Sun, Tong Zhu ^a   Cai, Cun Liang ^a   Zhou, Gang ^a   Chen, Wei ^a   Sheng, Zhi Yong ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

Acidic fibroblast growth factor; Apoptosis; Dysfunction; Ischemia reperfusion injury; Non mitogenic activity; Rat

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; CASPASE 3; LACTIC ACID; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRATE; NITRITE; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENTEROPATHY; HISTOPATHOLOGY; INTESTINE INJURY; INTESTINE ISCHEMIA; MITOGENESIS; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZATION; RAT; REPERFUSION INJURY; SUPERIOR MESENTERIC ARTERY OBSTRUCTION; WESTERN BLOTTING; WILD TYPE;

EID: 33846933568     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2006.04457.x     Document Type: Article

References (20)

1. Cronauer MV, Schulz WA, Seifert HH, Ackermann R, Burchardt M. Fibroblast growth factors and their receptors in urological cancers: basic research and clinical implications. Eur. Urol. 2003; 43: 309-19.
2. Fu XB, Li XK, Wang T, Cheng B, Sheng ZY. Enhanced anti-apoptosis and gut epithelium protection function of acidic fibroblast growth factor after cancelling of its mitogenic activity. World J. Gastroenterol. 2004; 10: 3590-6.
3. Cuevas P, Carceller F, Reimers D, Gimenez-Gallego G. Fibroblast growth factor-1 inhibits medial smooth muscle cell apoptosis after balloon injury. Neurol. Res. 2000; 22: 185-8.
4. Chen W, Fu XB, Ge SL et al. Intravenous acid fibroblast growth factor protects intestinal mucosal cells against ischemia-reperfusion injury via regulating Bcl-2/Bax expression. World J. Gastroenterol. 2005; 11: 3419-25.
5. Iwakura A, Fujita M, Ikemoto M et al. Myocardial ischemia enhances the expression of acidic fibroblast growth factor in human pericardial fluid. Heart Vessels 2000; 15: 112-16.
6. Skjerpen CS, Wesche J, Olsnes S. Identification of ribosome-binding protein p34 as an intracellular protein that binds acidic fibroblast growth factor. J. Biol. Chem. 2002; 277: 23 864-71.
7. Yura Y, Yoshioka Y, Yamamoto S et al. Enhancing effects of fibroblast growth factor on the proliferation of salivary gland carcinoma cells and salivary gland carcinogenesis. J. Oral Pathol. Med. 2001; 30: 159-67.
8. Wu X, Su Z, Li X, Zheng Q, Huang Y, Yuan H. High-level expression and purification of a nonmitogenic form of human acidic fibroblast growth factor in Escherichia coli. Protein Expr. Purif. 2005; 42: 7-11.
9. Maheshwari A, Christensen RD, Calhoun DA, Dimmitt RA, Lacson A. Circulating CXC-chemokine concentrations in a murine intestinal ischemia-reperfusion model. Fetal Pediatr. Pathol 2004; 23: 145-57.
10. Demircan M, Cetin S, Uguralp S, Sezgin N, Karaman A, Gozukara EM. Plasma D-lactic acid level: a useful marker to distinguish perforated from acute simple appendicitis. Asian J. Surg. 2004; 27: 303-5.
11. Millar CG, Thiemermann C. Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition. Br. J. Pharmacol. 1997; 121: 1824-30.
12. Inman SR, Davis NA, Mazzone ME, Olson KM, Lukaszek VA, Yoder KN. Simvastatin and L-arginine preserve renal function after ischemia/reperfusion injury. Am. J. Med. Sci. 2005; 329: 13-17.
13. Patel NS, Cortes U, Di Poala R et al. Mice lacking the 110-kD isoform of poly (ADP-ribose) glycohydrolase are protected against renal ischemia/reperfusion injury. J. Am. Soc. Nephrol. 2005; 16: 712-19.
14. Turnage RH, Guice KS, Oldham KT. Endotoxemia and remote organ injury following intestinal reperfusion. J. Surg. Res. 1994; 56: 571-8.
15. Poeze M, Solberg BC, Greve JW, Ramsay G. Gastric PgCO2 and PgaCO2 gap are related to D-lactate and not to L-lactate levels in patients with septic shock. Intensive Care Med. 2003; 29: 2081-5.
16. Van Putte BP, Kesecioglu J, Hendriks JM et al. Cellular infiltrates and injury evaluation in a rat model of warm pulmonary ischemia-reperfusion. Crit. Care 2005; 9: R1-8.
17. Fiordaliso F, Chimenti S, Staszewsky L et al. A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia-reperfusion injury. Proc. Natl Acad. Sci. USA 2005; 102: 2046-51.
18. Tsung A, Kaizu T, Nakao A et al. Ethyl pyruvate ameliorates liver ischemia-reperfusion injury by decreasing hepatic necrosis and apoptosis. Transplantation 2005; 79: 196-204.
19. Bredesen DE. Neural apoptosis. Ann. Neurol. 1995; 38: 839-41.
20. Roux PP, Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol. Mol. Biol. Rev. 2004; 68: 320-44.